Interestingly, a heparin-binding growth factor, midkine (MK), derived from CAFs, provides cisplatin resistance to oral squamous cell carcinoma (OSCC), lung cancer, and ovarian cancer cells by enhancing the expression levels of the lncRNA-ANRIL [Figure 2A]. This evidence concerns the gene MDK and ovarian carcinoma.